Skip to main content
SpringerLink
Log in

Putative mechanisms for vascular damage by homocysteine

  • Published:
Journal of Inherited Metabolic Disease

Abstract

In homocystinuria homocysteine appears to be directly toxic to the vasculature, but in mild hyperhomocysteinaemia a cause and effect relationship remains unproven. Evidence for a causal role is derived from recent primate and human studies in which endothelial dysfunction was produced by modestly elevated blood homocysteine concentrations. Endothelial dysfunction would account for an increased risk of both arterial and venous disease. A key abnormality may be impaired release and/or action of nitric oxide in response to flow. Other possible mechanisms include smooth muscle cell proliferation, extracellular matrix modification and lipoprotein oxidation. Although demonstrated in vitro, a role for lipoprotein oxidation in man has not been substantiated. However an effect of homocysteine on cellular redox status remains a possible mechanism. Homocysteine does not appear to alter circulating coagulation factors consistently, but may promote enhanced thrombin production indirectly by its effects on endothelium. Further studies are required to elucidate the pathological actions of homocysteine, concentrating on the effects of mild hyper-homocysteinaemia on endothelial function in man.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  • Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, Nordrehaug JE (1995) Serum total homocysteine and coronary heart disease. Int J Epidemiol 24: 704–709.

    Google Scholar 

  • Bellamy MF, Ramsey MW, Brownlee M, et al (1996) Abnormal flow-mediated brachial artery responses in subjects with hyperhomocysteinaemia and low vitamin B12/folate status. J Inher Metab Dis 19(supplement 1): 23.

    Google Scholar 

  • Blom HJ, Kleinveld HA, Boers GHJ, et al (1995) Lipid peroxidation and susceptibility of lowdensity lipoprotein to in vitro oxidation in hyperhomocysteinaemia. Eur J Clin Invest 25: 149–154.

    Google Scholar 

  • Blundell G, Jones BG, Rose FA, Tudball N (1996) Homocysteine mediated endothelial cell toxicity and its amelioration. Atherosclerosis 122: 163–172.

    Google Scholar 

  • Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. J Am Med Assoc 274: 1049–1057.

    Google Scholar 

  • Busse R, Fleming I (1996) Endothelial dysfunction in atherosclerosis. J Vasc Res 33: 181–194.

    Google Scholar 

  • Celermajer DS, Sorensen K, Ryalls M, et al (1993) Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not their heterozygous parents. J Am Coll Cardiol 22: 854–858.

    Google Scholar 

  • Den Heijer M, Koster T, Blom HJ, et al (1996) Hyperhomocysteinaemia as a risk factor for deepvein thrombosis. N Engl J Med 334: 759–762.

    Google Scholar 

  • Dudman NPB, Hicks C, Wang J, Wilcken DEL (1991) Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. Atherosclerosis 91: 77–83.

    Google Scholar 

  • Dudman NPB, Wilcken DEL, Stocker R (1993) Circulating lipid hydroperoxide levels in human hyperhomocysteinaemia. Arterioscler Thromb 13: 512–516.

    Google Scholar 

  • Flavahan NA (1992) Atherosclerosis or lipoprotein-induced endothelial dysfunction. Circulation 85: 1927–1938.

    Google Scholar 

  • Gibson JB, Carson NAJ, Neill DW (1964) Pathological findings in homocystinuria. J Clin Pathol 17: 427–437.

    Google Scholar 

  • Harker LA, Ross R, Slichter SJ, Scott CR (1976) Homocysteine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 58: 731–741.

    Google Scholar 

  • Harpel PC, Chang VT, Borth W (1992) Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis and sulfhydryl compound metabolism. Proc Natl Acad Sci USA 89: 10193–10197.

    Google Scholar 

  • Jia L, Furchgott RF (1993) Inhibition by sulphydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor. J Pharmacol Exp Ther 267: 371–378.

    Google Scholar 

  • Joannides R, Haefeli W, Linder L (1995) Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91: 1314–1319.

    Google Scholar 

  • Kielty CM, Wilson DG, Stuart G, et al (1996) Fibrillin expression and deposition by vascular endothelial cells: implications for the Marfan syndrome. Circulation 94(no. 8, supplement): I–350.

    Google Scholar 

  • Lentz SR, Sobey CG, Piegors DJ, et al (1996) Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest 98: 24–29.

    Google Scholar 

  • Loscalzo J (1996) The oxidant stress of hyperhomocysteinaemia [editorial]. J Clin Invest 98: 5–7.

    Google Scholar 

  • Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GHJ (1996) Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1315: 159–162.

    Google Scholar 

  • Mandel H, Brenner B, Berant M, et al (1996) Coexistence of hereditary homocystinuria and factor V Leiden-effect on thrombosis. N Engl J Med 334: 763–768.

    Google Scholar 

  • McCully KS, Wilson RB (1975) Homocysteine theory of arteriosclerosis. Atherosclerosis 22: 215–227.

    Google Scholar 

  • Mudd SH, Skovby F, Levy HL, et al (1985) The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 37: 1–31.

    Google Scholar 

  • Mudd S, Levy HL, Skovby F (1995) Disorders of transsulfuration. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw Hill: 1279–1323.

    Google Scholar 

  • Olszewski AJ, McCully KS (1993) Homocysteine metabolism and the oxidative modification of proteins and lipids. Free Radical Biol Med 14: 683–693.

    Google Scholar 

  • Palmer R, Ashton D, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664–666.

    Google Scholar 

  • Rees MM, Rodgers GM (1993) Homocysteinaemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 71: 337–359.

    Google Scholar 

  • Ross R (1986) The pathogenesis of atherosclerosis — an update. N Engl J Med 314: 488–500.

    Google Scholar 

  • Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801–809.

    Google Scholar 

  • Stamler JS, Loscalzo J (1992) Endothelium-derived relaxing factor modulates the atherothrombogenic effects of homocysteine. J Cardiovasc Pharm 20(supplement 12): S202–S204.

    Google Scholar 

  • Stamler JS, Osborne JA, Jaraki O, et al (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91: 308–318.

    Google Scholar 

  • Stampfer MJ, Malinow MR, Willet WC, et al (1992) A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J Am Med Assoc 268: 877–881.

    Google Scholar 

  • Starkebaum G, Harlan JM (1986) Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 77: 1370–1376.

    Google Scholar 

  • Tsai JC, Wang H, Perrella MA, et al (1996) Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 97: 146–153.

    Google Scholar 

  • Upchurch GR, Welch GN, Freedman JE, Loscalzo J (1995) Homocysteine attenuates endothelial glutathione peroxidase and thereby potentiates peroxide-mediated cell injury. Circulation 92: I–228.

    Google Scholar 

  • Wall RT, Harlan JM, Harker LA, Striker GE (1980) Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res 18: 113–121.

    Google Scholar 

  • Wilson DG, Bellamy MF, Goodfellow J, et al (1996) Abnormal flow-mediated brachial artery responses in patients with the Marfan syndrome. Circulation 94(no. 8, supplement): I–105.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Sciences Research Group, University of Wales College of Medicine, Cardiff, UK

    M. F. Bellamy & I. F. W. McDowell

  2. Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff, CF4 4XN, UK

    I. F. W. McDowell

Authors
  1. M. F. Bellamy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. F. W. McDowell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bellamy, M.F., McDowell, I.F.W. Putative mechanisms for vascular damage by homocysteine. J Inherit Metab Dis 20, 307–315 (1997). https://doi.org/10.1023/A:1005377310872

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005377310872

Keywords

Search

Navigation